Replies to post #23207 on Cytodyn Inc (CYDY)

[Saltz]

Rumor has it June18-20 window set for FDA meeting but what do I know. Outcome will have to be PR’d.

I too am hopeful Mono Trial will be discussed and given the green light to convert to Pivotal P3. Also anxious to hear Interim efficacy w the increased dosage.

To me BLA acceptance and Mono conversion are the needle movers. If BP looks at the Mono Interim and calculates there is a realistic chance for future approval it won’t matter what the SP is they will be forced to move and pay plenty.

Have to believe things are coming to a head. Can’t keep a lid on the valuation of this science forever.